Raja Pramanik

15PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsDisease surveillanceHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 24, 2025
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India.

Sneh Bhargave, Vinod Sharma, Babita Kataria

|Feb 08, 2025
Toxicity of anti-cancer drugs: the imaging findings to watch out for in common cancers.

Vishnu Prasad Pulappadi, Krithika Rangarajan, Raja Pramanik

|Nov 21, 2024
Deep Diving Into the Fusion Across Cancer Types in the Indian Population From Formalin-Fixed Paraffin-Embedded RNA-Exome Data: A Road to Discovering Novel Rearrangements With Clinical Relevance.

Satya Prakash Khuntia, Nilesh Mukherjee, Vyomesh Javle

|Feb 27, 2024
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.

Akhil Santhosh, Atul Sharma, Sameer Bakhshi

|Feb 22, 2024
SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer.

Chitrakshi Nagpal, Atul Sharma, Sameer Bakhshi

|Feb 08, 2024
Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights.

Deepak Verma, Shruti Kapoor, Sarita Kumari

Pageof 3

Frequent Collaborators

5 joint publications

Sameer Bakhshi

5 joint publications

Atul Sharma

3 joint publications

Sunila Kumar

3 joint publications

Prabhat Singh Malik